Cargando…
Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy
On 1 January 2005, a controversial trade agreement entered into force between Australia and the United States. Though heralded by the parties as facilitating the removal of barriers to free trade (in ways not achievable in multilateral fora), it also contained many trade-restricting intellectual pro...
Autores principales: | Faunce, Thomas, Doran, Evan, Henry, David, Drahos, Peter, Searles, Andrew, Pekarsky, Brita, Neville, Warwick |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1276805/ https://www.ncbi.nlm.nih.gov/pubmed/16209703 http://dx.doi.org/10.1186/1744-8603-1-15 |
Ejemplares similares
-
Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal
por: Faunce, Thomas A
Publicado: (2007) -
'Linkage' pharmaceutical evergreening in Canada and Australia
por: Faunce, Thomas A, et al.
Publicado: (2007) -
From conceptual pluralism to practical agreement on policy: global responsibility for global health
por: Ruger, Jennifer Prah, et al.
Publicado: (2015) -
Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good
por: Faunce, Thomas Alured
Publicado: (2006) -
The global workforce shortages and the migration of medical professions: the Australian policy response
por: Smith, Saxon D
Publicado: (2008)